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Severe and/or recurrent infection with Herpes simplex virus (HSV) is observed in a large
group of patients treated in clinical immunology facilities. Atypical and prolonged HSV
infection is the most common clinical manifestation of disturbed NK cell development and
functions, yet the molecular basis of these disorders is still largely unknown. Since recent
findings indicated the importance of miRNA in regulating NK cell development, maturation
and functions, the aim of our study was to investigate miRNA expression pattern in NK
cells in patients with severe and/or recurrent infections with HSV and analyze the role of
these miRNAs in NK cell antiviral response. As a result, miRNA expression pattern analysis
of human best known 754 miRNAs revealed that patients with severe and/or recurrent
HSV infection had substantially upregulated expression of four miRNAs: miR-27b, miR-
199b, miR-369-3p and miR-491-3p, when compared to healthy controls. Selective
inhibition of miR-27b, miR-199b, miR-369-3p and miR-491-3p expression in NK-92
cells resulted in profound upregulation of 4 genes (APOBEC3G, MAP2K3, MAVS and
TLR7) and downregulation of 36 genes taking part in antiviral response or associated with
signaling pathways of Toll-like receptors (TLR), NOD-like receptors, the retinoic acid-
inducible gene I (RIG-I)-like receptors (RLRs) and type I IFN-related response. Additionally,
flow cytometry analysis revealed that miR-369-3p and miR-491-3p inhibitors
downregulated NK cell intracellular perforin expression, while the expression of
granzyme B and IFNg remained unchanged. Taken together, our study suggests a
novel mechanism which may promote recurrence and severity of HSV infection, based
on miRNAs-dependent posttranscriptional regulation of genes taking part in antiviral
response of human NK cells.
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Severe and/or recurrent infections with HSV are observed in a
considerable group of patients treated in clinical immunology
facilities. Atypical and prolonged HSV infection is the most
common clinical manifestation of disturbed antiviral response
caused by primary NK cell deficiencies, that results from either
reduced/absent number of NK cells or disturbed function of
these cells (1–3). Nonetheless, in a large group of patients
suffering from severe and/or recurrent HSV infection who
exhibit normal NK cell numbers and NK cell cytotoxic activity,
the molecular basis of their disorder is still largely unknown.
Infections with Herpes viruses are mainly controlled by natural
killer (NK) cells, as a part of innate immunity. NK cells are large,
granular lymphocytes and their peripheral blood frequency varies
between 5 and 20% (4). NK cells have several surface markers/
receptors, such as CD16 (Fc gamma receptor type III), important
receptor in antibody-dependent cellular cytotoxicity (ADCC) (5) or
CD56, characteristic of NK cells producing large amounts of
cytokines (6). NK cells kill infected or neoplastic cells. The lysis of
altered cell occurs via perforin (Prf) and granzymes, secreted from
cells’ lysosomes, or through Fas ligand, tumor necrosis factor (TNF)
or TNF-related apoptosis-inducing ligand (7). NK cells can also
secrete a number of cytokines and chemokines, such as interferon g
(IFN-g), crucial in antiviral response; TNF, granulocyte-macrophage
colony-stimulating factor (GM-CSF), interleukin 5 (IL-5), IL-13,
macrophage inflammatory protein (MIP-1) and RANTES (6). The
release of these cytokines activates Th1 response, macrophage-
mediated killing of intracellular pathogens and up-regulates major
histocompatibility complex (MHC) class I molecules expression. NK
cells can also provide a co-stimulatory signal to T and B
lymphocytes, through CD40L and OX40L (8).
NK cells play a vital role in the control of a number of human
viruses. Several studies demonstrated NK cell-dependent
protective effects during infections with coxsackievirus, human
immunodeficiency virus (HIV), hepatitis C virus (HCV),
influenza virus and poxvirus, but most importantly, Herpes
viruses (7). Furthermore, the most common manifestation of
NK cell deficiency, both in number and function, is severe,
recurrent or disseminated infection with herpesviruses,
including HSV, Varicella zoster virus (VZV), cytomegalovirus
(CMV), Epstein-Barr virus (EBV), etc (2, 7).
The discovery of miRNAs has revealed a new mechanism of
gene expression regulation that affect many biological systems,
including mammalian immune system. miRNA are small, single-
stranded non-coding RNA that negatively regulate gene
expression by inducing their degradation or repress translation
of the target protein-coding mRNA (9). They are encoded by
genomic DNA, transcribed by RNA polymerase II and processed
from their primary transcript by the enzymes Drosha and
DiGeorge syndrome critical region gene 8 (DCGR8). Pre-
miRNA are then exported from the nucleus by exportin 5, and
after reaching cytoplasm, are further processed by Dicer,
resulting in the formation of miRNA duplex. The duplex is
packaged into RNA-induced silencing complex (RISC), which
comprises several proteins, including Argonaute. The miRNA
guides the complex to its 3’ UTRs, leading to inhibition ofFrontiers in Immunology | www.frontiersin.org 2translation or decrease of mRNA stability (9, 10). miRNA
themselves are coordinately modulated by different effectors
when carrying out basic functions. Studies of miRNA show
development- and tissue-specific regulation mechanisms,
although a considerable amount of known miRNA are
expressed universally in various tissues and species (11).
miRNA are regulated at the multiple steps of their biogenesis,
by sequence-specific RNA binding proteins and double-strand
RNA binding domains, as well as by other mechanisms,
including RNA editing or methylation (12). miRNA plays a
pivotal role in every aspect of cellular activity, such as
differentiation, development, metabolism, proliferation and
apoptotic cell death. miRNA is also associated with molecular
mechanisms of various human diseases, including viral
infections and tumorigenesis. Currently, approximately 2,300
human miRNAs have been discovered (13).
Recent advances highlight the importance of miRNA in
regulating NK cell development, maturation and functions
(14–18). In mice, Dicer- and Dcgr8-deficient NK cells were
significantly impaired in survival and turnover, and had
impaired function of ITAM-containing activating cell receptors
(17), while Dicer-deficient NK cells exhibited reduced survival
and impaired maturation with enhanced degranulation and IFN-
g production in response to cytokines (19). The role of specific
miRNAs in NK cells has also been studied. For example,
modulation of miR-150 expression levels has a different effect
of NK cells development (20). A number of miRNAs has also
been implied to be crucial for NK cell functionality. A number of
miRNAs, such as hsa-miR-155 and hsa-miR-181, regulate
expression of IFN-g in NK cells (19, 21), while other, i.e. miR-
223, miR-27a-5p, miR-150, miR-378, and miR-30e, has been
reported to suppress the cytotoxic capabilities of NK cells by
repressing perforin or granzyme B (22–25).
Recent studies have also shown that pathogens can influence
miRNA regulation of NK cell functions in order to evade immune
response. Among herpesviruses, targeted miR-155 deletion in
murine NK cells result in dramatically diminished effector
activities and reduce memory cell numbers in both lymphoid and
non-lymphoid tissues after murine CMV infection (26). However,
little is known about a possible association of disturbance of
miRNA regulation and severe, prolonged HSV infection.
The aim of the study was to investigate 1) miRNA expression
pattern in NK cells in patients with severe and/or recurrent HSV
infections, and to describe 2) which miRNAs might be associated
with increased susceptibility to prolonged and severe HSV
infection, and 3) define the genes associated with antiviral
response which expression is altered by studied miRNAs, in
order to predict the possible new mechanism of NK cell
deficiency leading to propagation of HSV infection.MATERIALS AND METHODS
Patients and Control Group
Thirty-eight patients with severe and/or recurrent HSV-1
infection, including children after HSV-1 infection of central
nervous system or ocular infections (3 girls and 2 boys), childrenJanuary 2021 | Volume 11 | Article 589866
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boys), children with accompanying recurrent VZV infection
(1 girl and 2 boys) and thirty-nine healthy children (16 girls
and 23 boys) were evaluated in this study. There were 2 patients
classified to more than one group (1 patient was in group of
orolabial herpes and disseminated skin infection, 1 patient was in
group of disseminated skin infections and VZV infections)
(Table 1).
All patients were under supervision of the outpatient units of
the Department of Clinical Immunology of the University
Children’s Hospital in Krakow. The study was approved by the
Bioethical Committee of the Jagiellonian University (KBET/284/
B/2013).
NK Cell Isolation
NK cells were isolated from blood samples obtained from
analyzed patients and healthy controls. In brief, peripheral
blood mononuclear cells (PBMC) isolated from EDTA-treated
whole peripheral blood by the standard Ficoll/Isopaque
(Pharmacia, Uppsala, Sweden) density gradient centrifugation.
NK cells were isolated from PBMC using MACS technology and
a NK cell isolation kit (Miltenyi Biotech), in which NK cells were
isolated via negative selection. In particular, non-NK cells were
labeled with a cocktail of biotin-conjugated antibodies and anti-
biotin magnetic beads and were then depleted by passage
through a paramagnetic MS Columns (Miltenyi Biotech).
miRNA Expression Analysis
miRNA expression analysis was performed in NK cell population
isolated from patients and healthy controls. In brief, the total
RNA, enriched in small RNAs, was extracted from NK cell
samples using High Pure miRNA Isolation Kit (Roche,
Germany) according to the manufacturer’s protocol. The first
strand cDNA was obtained from the total RNA (400 ng) samples
with Megaplex™ RT Primers (pool A and B, Applied Biosystems,
Foster City, CA). miRNA expression profile analysis was
performed using TaqMan Array Human MicroRNA Card Set
v3.0 (Applied Biosystems) according to manufacturer’s protocol.
Real-time PCR was performed using the QuantStudio 7 System
(Applied Biosystems). Data was analyzed using ExpressionSuite
version 1 software (Applied Biosystems). The results were shown
on volcano plot (p-value vs. fold change), with following settings:
fold change boundary 2,0 and p-value boundary 0,05. Volcano
plot was performed using GraphPad Prism version 6 software.Frontiers in Immunology | www.frontiersin.org 3The expression of miRNAs that were significantly elevated in
patients vs. control group and the differences reached statistical
significance were analyzed again, by individual real-time PCRs
(TaqMan Gene Expression Assays, Applied Biosystems). Briefly,
reverse transcription was performed as described above (Megaplex
RT primers pool A or B were used for the selected miRs andU6 as a
control) and the PCR reactions were performed in triplicates using
the QuantStudio 7 System (Applied Biosystems). The fluorescent
signals generated during the informative log-linear phase were used
to calculate the relative amount of miRs, while U6 was used as a
control for each PCR run. The expression of each miRNA was
calculated using 2−DDCT method.
Cell Cultures
Natural Killer Cell line (NK-92) were originally obtained from
ATCC (ATCC, Manassas, USA). Cells were cultured in the
Alpha Minimum Essential Medium without ribonucleosides
and deoxyribonucleosides but with sodium bicarbonate (MEM,
Corning, New York, USA) supplemented with 2mM L-
Glutamine (Thermo Fisher Scientific, Waltham, USA), 0.2mM
myo-Inositol (Sigma-Aldrich, Taufkirchen, Germany), 50mM b-
mercaptoethanol (Sigma-Aldrich, Taufkirchen, Germany),
0.02mM Folic Acid (Sigma-Aldrich, Taufkirchen, Germany),
150U/ml recombinant human Il-2 (Thermo Fisher Scientific,
Waltham, USA), 12.5% Horse Serum (Thermo Fisher Scientific,
Waltham, USA) and 12.5% foetal bovine serum (EURx, Gdansk,
Poland). Cells were passaged 24h before all experiments using
standard protocol to a 24-well plate.
Transfection With miRNA Inhibitors
NK-92 cells were transfected with the 500nM of 3’-6-fluorescein
(6-FAM) conjugated LNA anti-miR-27b, anti-miR-199b, anti-
miR-369-3p, and anti-miR-491-3p (miRCURY LNA miRNA
Power Inhibitor, 3’-FAM conjugated, Exiqon) without
transfection reagent. Alternatively, cells were transfected with
500nM negative control miR or in the absence of miR inhibitors.
After 48h of transfection cells were centrifuged at 200g for 5 min,
suspended in PBS and sorted as described below. After sorting,
cells were seeded into 24-well plate for 24h and then stimulated
with 0.2µg/mL phorbol 12-myristate 13-acetate (PMA, Sigma-
Aldrich, Taufkirchen, Germany), 0.5µg/mL Ionomycin (Sigma-
Aldrich, Taufkirchen, Germany) and 50ng/mL IL-12 (Fisher
Scientific, Waltham, USA) for 3h. Next, cells were harvested
and RNA isolation was performed, as described below.TABLE 1 | Characteristic of patients and control group.
Orolabial HSV Disseminated skin HSV HSV ocular/CNS infection Accompanying recurrent VZV infection Control
Number of children 20 14 5 3 39
Age
(years ± SD)
7 ± 7 4 ± 3 11 ± 5 7 ± 5 8 ± 6
Sex (F/M) 7/13 5/9 3/2 1/2 16/23
NK numbers (n)
normal 16 8 4 2 ND
decreased 1 4 0 0 ND
increased 3 2 1 1 NDJanuary 2021 | Volume 11 | ArticleND, no data.589866
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The NK-92 cells transfected with miRNA inhibitors were
suspended in phosphate-buffered saline buffer (PBS) and sorted
using the FACSAria II cell sorter (BD Biosciences, San Jose, CA,
USA). The cells were sorted to obtain FAM- miRNA inhibitors-
transfected cells. Sorter was equipped with 488 nm laser for
excitation of FITC and PE. The following band-pass filters were
used for the measurement of fluorescence (wavelength in nm/
power in mW): 530/30 for FITC and 582/15 for PE. Data was
acquired and analyzed using BD FACSDiva™ Software (Becton
Dickinson). Sorting was performed using 85 µm nozzle with the
sheath pressure set at 45 PSI and a flow rate dependent on the
concentration of cells, at the sort rate of less than 3600 events/s,
using the sort precision mode set for “Good Purity” to obtain pure
(usually 97–98%) subpopulations. Sorted cells were collected into
FBS-coated polypropylene tubes (BD Biosciences).
Antiviral Response Gene Expression
Analysis
Total RNA was extracted from cell suspension using GenElute™
Total RNA Purification Kit (Sigma Aldrich), then cDNA was
generated with the iScript Advanced cDNA synthesis kit (Biorad,
Carlsbad CA). For antiviral response gene expression analysis,
the PrimePCR predesigned plates (384-well format, Bio-Rad)
were used, altogether with SsoAdvanced SYBR Green supermix
(Bio-Rad), according to manufacturer’s protocol. Real-time PCR
reaction was performed on QuantStudio 7 System. Data analysis
was performed with PrimePCR Analysis Software V1.0 (Bio-
Rad). The expression of each gene was presented as relative
expression normalized to GAPDH, which presented the lowest
expression variability.
Flow Cytometry
Intracellular staining of granzyme B (GrmzB), perforin (Prf) and
IFNg was performed in NK-92 cells transfected with miRNA
inhibitors as described above. NK-92 cells were stimulated for 6h
with 0,2µg/mL PMA (Sigma-Aldrich, Taufkirchen, Germany),
0.5µg/mL Ionomycin (Sigma-Aldrich, Taufkirchen, Germany),
50ng/mL IL-12 (Fisher Scientific, Waltham, USA) in the
presence of BD Golgi Stop (Biosciences, Heidelberg, Germany)
according to manufacturer’s instructions. Cells were then washed
with PBS, fixed/permeabilized with Cytofix/Cytoperm (BD
Biosciences) reagent (20 min, 4°C) and washed twice with
Perm/Wash solution (BD). Then, mAbs for intracellular
staining were added and the samples were incubated for
30 min at 4°C. The following mouse monoclonal antibodies
(mAbs) against human molecules were used: anti-GrzmB PE
(clone GB11, Affymetrix, San Diego, CA), anti-Prf PE (clone
delta G9, BD Bioscience Pharmigen) and anti-IFNg APC (clone
25723.11, BD FastImmune). Afterwards, the cells were washed
twice in Perm/Wash solution and resuspended in PBS for flow
cytometry analysis, which was performed using FACSCanto10
flow cytometer (Becton Dickinson Immunocytometry Systems,
Palo Alto, CA).
For all staining experiments, appropriate isotype-matched
controls were included. The cells that were positivelyFrontiers in Immunology | www.frontiersin.org 4transfected with the inhibitors were determined on the basis of
FAM expression. Data analysis was performed using FlowJo
software (Tree Star, Inc, Ashland, OR). The expression of
analyzed receptors was assessed and presented as a percentage
and median fluorescent intensity (MFI).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism version
6 (GraphPad Software Inc., San Diego, CA). The normal
distribution of values was verified using Shapiro-Wilk test. A
non-parametric Kruskal-Wallis test with Dunn’s post-hoc test was
used and median ± interquartile range (IQR: Q1—25%, Q3—
75%) was shown. The P values <0.05 were considered significant.RESULTS
miRNA Expression Pattern Analysis in NK
Cells
To evaluate the miRNAs expression pattern in NK cells of
patients with severe and/or recurrent HSV infection and
healthy control subjects, we performed real-time PCR
quantification of the best known 754 human miRNAs in NK
cells isolated from peripheral blood of all analyzed individuals.
As a result, we noticed nine miRNAs that differed between
patient and control group (fold change of DCt values of the
miRNAs was higher than 2) and the difference was statistically
significant (Figure 1), where the expression of four miRNA
was significantly upregulated in patients group and five were
significantly downregulated in patient group (miR-99b, miR-
181c, miR-519e, miR-500, miR-552), when compared to healthy
controls (Figure 1A). Since here we decided to focus on miRNAs
which expression was significantly elevated in patient group, we
performed individual real-time PCR reactions for these four
miRNAs (miR-27b, miR-199b, miR-369-3p, and miR-491-3p)
in all patients and healthy subjects, in order to confirm primary
results. Again, the differences of analyzed miRNAs expression
between patients and control group reached statistical
significance (Figure 1B). These miRNAs were thus chosen for
further analysis.
The Effect of miRNA Inhibition on Antiviral
Gene Expression in NK-92
Next, we focused on the analysis of the role of selected miRNAs
in NK cells. Therefore, we performed functional inhibition of
each of the selected miRNAs in NK-92 cell line using specific
mRNAs inhibitors. NK-92 cells were transfected with anti-miR-
27b, anti-miR-199b, anti-miR-369-3p, and anti-miR-491-3p
inhibitors, simultaneously with a negative control inhibitor.
Preliminary experiments showed that transfection efficacy of
NK-92 cells with the inhibitors was low (app. 20%) (data not
shown) thus we decided to use the inhibitors that are conjugated
with 6-FAM which can be detected by flow cytometry, and
isolate positively transfected cells by FACS sorting. The cells
viability after transfection was analyzed during sorting on the
basis of FSC and SSC parameters, thus only living cells wereJanuary 2021 | Volume 11 | Article 589866
Lenart et al. miRNA in Severe/Recurrent HSV Infectiongated. All gated cells were 6-FAM-positive thus the transfection
efficacy was nearly 100% (Supplementary Figure 1) and similar
in all applied miRNA inhibitors. The cells were than seeded,
cultured overnight and stimulated with PMA, Ionomycin and IL-
12. Then, real-time PCR was performed in order to determine
the expression of 86 genes associated with antiviral response
using predesigned real-time PCR plates. The results were
presented as a relative expression after normalization to
GAPDH. In summary, 4 genes associated with antiviral
response were significantly upregulated and 36 downregulated
in NK-92 cells by at least one of the miRNA inhibitor, when
compared to negative control inhibitor (Table 2 and
Supplementary Figure S1). In particular, miR-27b inhibitor
significantly upregulated MAP2K3 (Figure 2V), MAVS (Figure
2AA) and TLR7 (Figure 2AI) genes, and downregulated IRAK-1Frontiers in Immunology | www.frontiersin.org 5(Figure 2T) and MAPK14 (Figure 2Z) gene expression. Anti-
miR-199b inhibitor significantly upregulated MAVS (Figure
2AA) gene and downregulated AZI2 (Figure 2B), CASP1
(Figure 2C), CASP8 (Figure 3D), CD40 (Figure 2G), CTSS
(Figure 2I), CXCL10 (Figure 2J), CXCL11 (Figure 2K),
DAK (Figure 2L), FADD (Figure 2N), IFNA1 (Figure 2O),
IFNA2 (Figure 2P), IFNAR1 (Figure 2Q), IFNB1 (Figure 2R),
MAP3K1 (Figure 2W), MAPK1 (Figure 2Y), MAPK14 (Figure
2Z), NOD2 (Figure 2AE), PIN (Figure 2AF), TLR8 (Figure
2AJ), TLR9 (Figure 2AK), and TRIM25 (Figure 2AN) gene
expression. Anti-miR-369-3p inhibitor significantly
downregulated CCL3 (Figure 2E), CCL5 (Figure 2F), CTSS
(Figure 2I), CXCL11 (Figure 2K), and IRF7 (Figure 2U) gene
expression. Anti-miR-491-3p inhibitor significantly upregulated
APOBEC3G (Figure 2A) and downregulated AZI2 (Figure 2B),A
B
FIGURE 1 | miRNA real-time PCR analysis. Volcano plot showing differential miRNA expression levels in patients with HSV infection in comparison to control group.
The vertical lines correspond to 2-fold up and down change and the horizontal line represents a P value of 0,05 (A). Expression of miRNAs miR-27b, miR-199b,
miR-369-3p and miR-491-3p presented as fold change of each miR relative expression normalized to U6 expression and healthy control group (2−DDCT). The results
were obtained from individual real-time PCR reactions performed in all patients and control subjects. Dashed line signifies the control group. Data was analyzed using
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genes
miR-27b Up TLR7, MAP2K3 n. d. MAVS n. d.
Down MAP3K7, MAPK1, MAPK14 n. d. AZI2, CASP1, MAP3K1, PIN1, TRADD IFNAR1, IL15,
miR-
199b
Up n. d. n. d. MAVS n. d.
Down CD40, CD86, CTSS, CXCL10, CXCL11,
IFNA1,
IFNA2, IFNB1, IRF7, MAP3K7, MAPK1,
MAPK14, NFKB1, NFKBIA, TLR8, TLR9
CASP1, NOD2, AZI2, CASP8, CXCL10, DAK, DDX58, FADD,





Up n. d. n. d. n. d. n. d.
Down CCL3, CCL5, CTSS, IRF7, IRAK1, NFKB1 n. d. DDX58, MAP3K1, TRADD n. d.
miR-
491-3p
Up APOBEC3G n. d. n. d. n. d.
Down CCL5, CD40, CD86, CTSS, CXCL10,
CXCL11,
IFNA1, IFNA2, IFNB1, IRAK1, IRF7, MAP3K7,




AZI2, CASP8, CXCL10, DAK, DDX58, FADD,
MAP3K1, MAPK14, NFKB1, NFKBIA, PIN1,
TRADD, TRAF6, TRIM25
IFNA1, IFNA2,
IFNAR1, IFNB1, IL15January 2021 | VolumGenes were grouped to TLR, NOD-like, RIG-I-like and type I IFN signaling pathway and responsive genes. n. d., not detected.e 11 | Article 589866
Lenart et al. miRNA in Severe/Recurrent HSV InfectionCASP1 (Figure 2C), CASP8 (Figure 2D), CCL5 (Figure 2F),
CD40 (Figure 2G), CD86 (Figure 2H), CTSS (Figure 2I), CXCL10
(Figure 2J), CXCL11 (Figure 2K), DAK (Figure 2L), DDX58MFrontiers in Immunology | www.frontiersin.org 6(Figure 2M), FADD (Figure 2N), IFNA1 (Figure 2O),
IFNA2 (Figure 2P), IFNAR1 (Figure 2Q), IFNB1 (Figure 2R),
IL15 (Figure 2S), IRAK1 (Figure 2T), IRF7 (Figure 2U),MAP3K1FIGURE 2 | Antiviral gene expression analysis. The effect of miR-27b, miR-199b, miR-369-3p and miR-491-3p inhibition in NK-92 cell line on antiviral response gene
expression analyzed by real-time PCR presented as relative expression normalized to GAPDH (2−DDCT). Only genes which expression was significantly altered by at least
one of the inhibitors are presented on the plot. APOBEC3G (A), AZI2 (B), CASP1 (C), CASP8 (D), CCL3 (E), CCL5 (F), CD40 (G), CD86 (H), CTSS (I), CXCL10 (J),
CXCL11 (K), DAK (L), DDX58 (M), FADD (N), IFNA1 (O), IFNA2 (P), IFNAR1 (Q), IFNB1 (R), IL15 (S), IRAK1 (T), IRF7 (U), MAP2K3 (V), MAP3K1 (W), MAP3K7 (X),
MAPK1 (Y), MAPK14 (Z), MAVS (AA), MYD88 (AB), NFKB1 (AC), NOD2 (AE), PIN1 (AF), PSTPIP1 (AG), TLR3 (AH), TLR7 (AI), TLR8 (AJ), TLR9 (AK), TRADD (AL),
TRAF6 (AM), TRIM25 (AN). Plots are presented in an alphabetic order. The data of the effect of each specific miRNA inhibitor was compared to negative control inhibitor.
Data was analyzed using non-parametric Kruskal-Wallis test with Dunn’s post-hoc test. Data from 3 independent experiments, median and interquartile range are shown.
Asterisks mark significant differences: *p < 0,05, **p < 0,01, ***p < 0,001. inh., inhibitor; n. s., not significant.January 2021 | Volume 11 | Article 589866
Lenart et al. miRNA in Severe/Recurrent HSV Infection(Figure 2W), MAP3K7 (Figure 2X), MAPK1 (Figure 2Y),
MAPK14 (Figure 2Z), MYD88 (Figure 2AB), NFKB1 (Figure
2AC), NFKBIA (Figure 2AD), NOD2 (Figure 2AE), PIN (Figure
2AF), PSTPIP1 (Figure 2AG), TLR3 (Figure 2AH), TLR8
(Figure 2AJ), TLR9 (Figure 2AK), TRADD (Figure 2AL),
TRAF6 (Figure 2AM), and TRIM25 (Figure 2AN) gene
expression. The expression of following genes was not altered by
miRNA inhibitors: ACTB, AIM2, ATG5, CARD9, CASP10, CD80,
CHUK, CTSB, CTSL1, CYLD, DHX58, FOS, HSP90AA1, IFIH1,
IKBKB, IL12A, IL1B, IL6, IL8, IRF3, IRF5, ISG15, JUN, MAP2K1,
MAPK3,MAPK8,MEFV, MX1, NLRP3, OAS2, PYCARD, PYDC1,
RIPK1, RPLP0, SPP1, STAT1, SUGT1, TBK1, TICAM1, TNF, and
TRAF3, when compared to negative control inhibitor. Four genes
were undetermined: CXCL9, DDX3X, IL12b, IL18.
The Effect of miRNA Inhibition
on Prf, GrzmB, and IFNg Expression
in NK-92 Cells
At last, we additionally analyzed the expression of Prf, GrzmB
and IFNg intracellular expression in NK-92 cells transfected with
miR-27b, miR-199b, miR-369-3p and miR-491-3p inhibitors by
flow cytometry (Figure 3). The results showed that only perforin
expression was significantly upregulated in NK-92 cells
transfected with miR-369-3p or miR-491-3p inhibitors, when
compared to negative control (Figures 3A, D). In the case of
miR-369-3p inhibitor, both the percentage of cells expressing
perforin, and perforin MFI was markedly elevated, while in the
case of miR-491-3p inhibitor we only noted upregulation of the
percentage of Prf-positive cells. There were no differences in the
percentage of cells or MFI when GrzmB (Figures 3B, E) and
IFNg (Figures 3C, F) expression was analyzed.Frontiers in Immunology | www.frontiersin.org 7DISCUSSION
In this report, we show that NK cells isolated from patients suffering
from severe and/or recurrent HSV infection had dysregulated
miRNA expression, what may alter antiviral response of these
cells and, as a consequence, escalate HSV infection.
First of all, the results of miRNA expression profiling showed
that patients suffering from severe and/or recurrent HSV
infection had significantly upregulated expression of four
miRNAs: hsa-miR-27b, hsa-miR-199b, hsa-miR-369-3p and
hsa-miR-491-3p, when compared to healthy control subjects.
None of these miRNAs has been previously reported to play an
important function in NK cells, although miR-27a, a close
homolog to miR-27b (20/21 nucleotide identity), was shown to
repress the cytotoxic capacity of NK cells (24). However, miR-
27b, miR-199b, and miR-491-3p had been previously associated
with viral infections, also caused by Herpesviruses. miR-27b was
up-regulated in human CMV-infected glioma cells (27), and
both miR-27a and miR-27b have antiviral activity against murine
CMV (28). miR-199b was significantly downregulated in
Kaposi’s sarcoma specimens (29), while miR-491 was one of
the several miRNAs which expression levels were altered by
HCV infection in hepatoma cells (30). There is limited data
about the role of miR-369-3p in immune response with most of
the research concerning its impact in different types of cancer
(31–33).
Selective inhibition of miR-27b, miR-199b, miR-369-3p and
miR-491-3p expression in NK-92 cells resulted in down- or
upregulation of a number of genes associated with antiviral
response. These genes might be involved in the modulation of
4 signaling pathways: Toll-like receptor (TLR) signaling (34),A B
D E F
C
FIGURE 3 | Flow cytometry analysis. The effect of miR-27b, miR-199b, miR-369-3p and miR-491-3p inhibition in NK-92 cell line on perforin, granzyme B and IFNg
expression analyzed using flow cytometry. The percentage of cells expressing perforin (A), granzyme B (B) and IFNg (C), and MFI of perforin (D), granzyme B (E)
and IFNg (F) is shown. The data of the effect of each specific miRNA inhibitor was compared to negative control inhibitor. Data was analyzed using non-parametric
Kruskal-Wallis test with Dunn’s post-hoc test for multiple comparisons. Data from 5 independent experiments, median and interquartile range are shown. Asterisks
mark significant differences: *p < 0,05. inh., inhibitor; n. s., not significant.January 2021 | Volume 11 | Article 589866
Lenart et al. miRNA in Severe/Recurrent HSV InfectionNOD-like receptor signaling (35), the retinoic acid-inducible
gene I (RIG-I)-like receptors (RLRs) signaling (36) and type I
IFN signaling and response (37). To our surprise, among
analyzed miRNAs, miR-27b, miR-199b and miR-491-3p
inhibition resulted in upregulation of only four genes in total,
while the use of all four inhibitors resulted in downregulation of
36 genes altogether. Both miR-27b and miR-199b inhibition
resulted in upregulation of the mitochondrial innate immune
adaptor (MAVS) gene, while miR-27b inhibitor caused
upregulation of two more genes: MAP2K3 and TLR7. MAVS
(also known as IPS-1/VISA/Cardif) interacts with the retinoic
acid-inducible gene I (RIG-I)-like receptors (RLRs) such as RIG-I
and melanoma differentiation-associated gene 5 (MDA-5), which
recognize viral RNA, and activate the expression of type I
interferons and IFN-stimulated genes (ISGs) (38, 39). Although,
HSV is a double-strand DNA virus, it has evolved multiple
mechanisms to evade the host innate immune response,
including MAVS-mediated response and early ISGs production
(40, 41). Moreover, the absence of MAVS alters normal NK cell
development and maturation (42). Thus, we believe that MAVS
might be a key protein associated with alteration of NK immune
response against HSV caused by upregulation of miR-27b andmiR-
199b in our patients suffering from severe and/or recurrent HSV
infection. However, it should be also pointed out that although we
did not noticed upregulation of type I interferon signaling and
response genes followingMAVS upregulation, it is possible the time
point of harvesting NK-92 cells after stimulation was too short to
observe MAVS-mediated gene expression stimulation.
miR-27b inhibitor significantly upregulated TLR7 gene and
MAP2K3 gene, which mediate downstream signaling of TLR
receptors. TLR7 and TLR8 recognize the single-stranded RNAs
(ssRNAs) found in many viruses, leading to IFN-a production in
virus-infected macrophages and dendritic cells (43, 44). It has
been shown, though, that infection of human corneal epithelial
cell (HCEC) line by HSV-1, which is a dsDNA virus, can lead to
upregulation of TLR7 expression level and proinflammatory
cytokine and IFNs production (45). On the other hand,
MAP2K3 engagement in the activation of p38-STAT1 pathway
and activation of a subset of ISGs in antigen-presenting cells during
HIV-1 infection was previously reported to facilitates expansion of
the infection (46). MAP2K3/P38 MAPK signaling pathway plays
also essential role in coxsackievirus B3 infection, favoring viral
progeny release from infected cells (47). MAP2K3 has been also
shown to be inhibited by miR-21 (47), which promotes NK cell
proliferation (48). Taken together, it is possible that upregulation of
miR-27b expression in NK cells of our patients promotes HSV
infection. Moreover, MAP2K3/P38 MAPK signaling pathway
involvement in HSV infection needs further investigation.
miR-491-3p inhibition resulted in upregulation of
APOBEC3G (A3G) gene expression, which is a type I IFN-
responsive gene. A3G is a cytidine deaminase, an enzyme that
belongs to a larger group that can edit nucleic acids. A3G is as a
well-known interaction partner of the HIV-encoded Viral
Infectivity Factor (Vif) protein, which counteract the antiviral
activity of A3G proteins (49). However, increased expression of
A3G in NK cell lines profoundly alters the coding transcriptomeFrontiers in Immunology | www.frontiersin.org 8of NK cells observed under hypoxic stress (50). Since both
hypoxia and chronic infections are stress factors for NK cells,
we might assume that A3G could play an important role in NK
cell functions during prolonged HSV infection. Latent HCMV
infection has already been shown to downregulate APOBEC3G
in CD34+ progenitor cells (51).
To our surprise, a large number of antiviral response-
mediating genes were downregulated in NK-92 cells by
miRNA inhibitors. In particular, miR-27b inhibition resulted
in downregulation of MAP3K7, MAPK1 and MAPK14 genes,
coding TLRs signaling factors. Similarly, miR-369-3p inhibition
resulted in cathepsin S-coding gene CTSS, which is crucial in
regulating TLR9 signaling (52) and CCL3, CCL5, IRF7, IRAK1
and NFKB1 genes, encoding TLRs signaling factors. Both
inhibitors also downregulated several RIG-I-like receptors
signaling genes: AZI2, CASP1, MA3K1, PIN1 and TRADD (in
case of miR-27b) and, in case of miR-199b, DDX58, MAP3K1
and TRADD and type I IFN signaling genes: IFNAR1, IL15.
Moreover, the latter two miRNA inhibitors, specific for miR-
199b and miR-491, also contributed to downregulation of a
number genes coding for TLR signaling factors: TLR8, TLR9,
CTSS, IRF7, MAP3K1, MAP3K7, MAPK1, MAPK14, NFKB1,
NFKBIA, or TLR responsive genes: CD40, CD86, CXCL11,
IFNA1, IFNA2, and IFNB1. miR-491-3p inhibitor additionally
downregulated CLL5, IRAK1, MYD88 and TLR3 gene
expression. Both miRs inhibitors mediated downregulation of
genes belonging to NOD-like receptor signaling: CASP1, NOD2
(both miRs), PSTPIP1 (miR-491-3p); and RIG-I-like receptor
signaling and responsive genes: AZI2, CASP8, CXCL10, DAK,
DDX58M (RIG-I), FADD, IFNA1, IFNA2, IFNB1, PIN, TRADD
and TRIM25. Moreover, they also downregulated type I IFN
signaling- associated genes: IFNA1, IFNA2, IFNAR1, IFNB1 and
IL15. Since a number of genes downregulated by miR-199b and
miR-491-3p highly exceed a number of upregulated genes, we
think that upregulated expression of miR-199b and miR-491-3p
observed in our patients might not be directly associated with
NK cell function impairment, leading to observed prolonged
HSV infection, but provides a type of a compensation
mechanism enhancing defective NK cell function. However,
this issue requires further studies.
Flow cytometry analysis of Prf, GrzmB and IFNg intracellular
expression in NK-92 cells transfected with miR-27b, miR-199b,
miR-369-3p and miR-491-3p inhibitors revealed that Prf
expression (the percentage of perforin-expressing cells or perforin
MFI) was upregulated by miR-369-3p and miR-491-3p inhibitors,
while the expression of GrzmB and IFNg remained unchanged.
Previously, Prf has been shown to be posttranscriptionally regulated
by miR-30e (25) and miR-150 (23). GrzmB expression is targeted
by miR-378 (53), while miR-146a plays a negative role in IFN-g
production by human NK cells (54). Thus, this is the first report
indicating that miR-369-3p and miR-491-3p play a role in negative
regulation of perforin expression.
In conclusion, our study suggests a novel mechanism which
may promote recurrence and severity of HSV infection based on
the miRNAs-dependent posttranscriptional regulation of genes
taking part in antiviral response of human NK cells.January 2021 | Volume 11 | Article 589866
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